Figures & data
Figure 1 Flow diagram of the data screening.
![Figure 1 Flow diagram of the data screening.](/cms/asset/854ad077-f656-42db-a80e-0da18aa544cf/dmso_a_354611_f0001_c.jpg)
Table 1 Clinical Characteristics of the Study Population (N=13,980)
Table 2 Baseline Characteristics Were Analyzed by Multivariate Logistic Regression in the Training Group. (N= 10,485)
Figure 2 Demographic and clinical feature selection using the LASSO binary logistic regression model (figure was created by R software, “glmnet” package, version 2.0–18, https://CRAN.R-project.org/package=glmnet).
![Figure 2 Demographic and clinical feature selection using the LASSO binary logistic regression model (figure was created by R software, “glmnet” package, version 2.0–18, https://CRAN.R-project.org/package=glmnet).](/cms/asset/1eae4b67-0cee-4809-9d63-4d75c825119f/dmso_a_354611_f0002_c.jpg)
Figure 3 Nomogram to predict the risk of DR.
![Figure 3 Nomogram to predict the risk of DR.](/cms/asset/b21b4be3-4749-40e8-9a18-59b744842971/dmso_a_354611_f0003_c.jpg)
Figure 4 According to Nomogram’s estimate, the probability of DR risk in patient no.1020 (A) and no.2089 (B) was 0.12 and 0.816, respectively, P < 0.001.
![Figure 4 According to Nomogram’s estimate, the probability of DR risk in patient no.1020 (A) and no.2089 (B) was 0.12 and 0.816, respectively, P < 0.001.](/cms/asset/107b3a1e-8a81-4c57-a848-ca354debd1d3/dmso_a_354611_f0004_c.jpg)
Figure 5 The ROC curves of the nomogram for DR risk (left, development group, right, validation group. including ROC curves of single risk factor model).
![Figure 5 The ROC curves of the nomogram for DR risk (left, development group, right, validation group. including ROC curves of single risk factor model).](/cms/asset/be5ded2f-0d70-4cbd-8030-ac05b34b3eae/dmso_a_354611_f0005_c.jpg)
Figure 6 Calibration curves for the validation and development group models (left, development group, right, validation group).
![Figure 6 Calibration curves for the validation and development group models (left, development group, right, validation group).](/cms/asset/87a1cfe9-4875-44f6-8b3c-c1c87fc6bffb/dmso_a_354611_f0006_c.jpg)
Figure 7 The decision curve analysis of the nomogram for DR risk (left, development group, right, validation group).
![Figure 7 The decision curve analysis of the nomogram for DR risk (left, development group, right, validation group).](/cms/asset/729f8c46-c9be-4ad7-8d66-89ccd843889d/dmso_a_354611_f0007_c.jpg)